Peer-influenced content. Sources you trust. No registration required. This is HCN.
Mayo Clinic Labs
Hereditary TTP, an ultra-rare ADAMTS13 deficiency affecting roughly one in a million, is now managed with weekly recombinant ADAMTS13 infusions in a pediatric outpatient setting.
Hematology April 28th 2026